PeerView Rheumatology CME/CNE/CPE Audio Podcast
Summary: PeerView Press is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
- Visit Website
- RSS
- Artist: PVI, PeerView Institute for Medical Education
- Copyright: 2007
Podcasts:
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
This 3-part activity focuses on several aspects of the management of fibromyalgia. Highlights from the first part of the activity include the potential etiologies of fibromyalgia and tools to assist in the diagnosis of patients with this condition. The various types of pharmacologic and nonpharmacologic therapeutic approaches for fibromyalgia are discussed in the second part of the program. The third part of the activity addresses the treatment of comorbidity in patients with fibromyalgia. It also emphasizes the importance of an interdisciplinary approach for the management of fibromyalgia.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts in RA discuss current evidence on optimal management of early RA, including the use of biologic agents.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts in management of rheumatoid arthritis discuss the importance of early, aggressive management of rheumatoid arthritis.
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts in rheumatology discuss the latest data on treatment of RA, including the emerging evidence supporting early use of traditional and biologic antirheumatic drugs in undifferentiated arthritis and early stage RA, as well as up-to-date findings regarding the efficacy and safety of T- and B-cell-targeted biologics in RA.
In this activity, experts on SLE review current and emerging treatments, discuss the latest treatment guidelines from EULAR, and propose therapeutic strategies for patients with lupus nephritis.
In this activity, experts in the treatment of rheumatoid arthritis evaluate recent data on the impact of newer biologics on functional outcomes and quality-of-life parameters. A review of the efficacy and safety of these agents is featured.
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.
In this CME activity, an expert in the management of osteoporosis discusses optimal diagnostic approaches and recent data on strategies to manage this condition. The role of the rheumatologist in the management of osteoporosis is also reviewed.
Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file.
In this activity, experts in the treatment of rheumatoid arthritis (RA) discuss updated safety data associated with the use of abatacept or rituximab in methotrexate- or TNF-antagonist-refractory RA.